Matinas BioPharma
MTNB
MTNB
51 hedge funds and large institutions have $5.61M invested in Matinas BioPharma in 2023 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 8 increasing their positions, 10 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
less ownership
Funds ownership: →
20% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 10
Holders
51
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$127K | |
| 2 | +$71.7K | |
| 3 | +$50.8K | |
| 4 |
VF
Virtu Financial
New York
|
+$36.8K |
| 5 |
Renaissance Technologies
New York
|
+$35.5K |
Top Sellers
| 1 | -$98.1K | |
| 2 | -$86.7K | |
| 3 | -$62.1K | |
| 4 |
SIG
Sargent Investment Group
Bethesda,
Maryland
|
-$23.7K |
| 5 |
Squarepoint
New York
|
-$19.2K |